Overall, the state and 37 other attorneys general will get $68.5 million in the largest ever multistate consumer protection-based agreement with a pharmaceutical company.
AstraZeneca marketed its antipsychotic drug Seroquel for unapproved or off-label uses, according to a complaint that also said that it failed to adequately disclose potential side effects to health care providers and withheld negative information in scientific studies about safety and the effectiveness of the drug.
Under the settlement, AstraZeneca has to publicly post its payments to physicians on a website.
It also must implement policies to ensure financial incentives aren’t given to salespeople for off-label marketing and that those salespeople don’t promote the drug to health care providers that are unlikely to prescribe Seroquel for an FDA-approved use and cite the drug’s FDA-approved uses when referencing selected symptoms rather than promoting by highlighting symptoms only.
Comments | Share your thoughts »Related StoriesMore Business News headlinesAnti-subsidy fervor, high crop prices vex farmersStock market plunges in TokyoLet insurer spy on driving, get a discountMitsubishi Electric to build Memphis plant, hire up to 275Selected for you by a sponsor:ADVERTISEMENTTop Stories
Haslam: Economy improving, budget still tight- Hundreds of bodies wash ashore in quake-hit Japan - MTSU administrator survives climbing accident that killed his brother - Jackson Police: Fugitives tied up park workers, stole truck- See all Top StoriesMost Popular
Vandy expects Richmond to be no pushoverMonday's crime logLockout will affect Titans at more than quarterbackSecond explosion rocks stricken Japan nuclear plant; 11 workers injured17-year-old shot as friends play with gun at Antioch apartments
Most Commented
Antioch mosque embraces public134What's the least Christians can believe? Lebanon pastor asks in new book69Vandy expects Richmond to be no pushover51America is lacking effective leadership51Electoral college manipulates voters43ADVERTISEMENTTwo TNInvestco funds start medical device companyUnderwater? Alternatives to Walking Away
